A non-hallucinogenic version of the psychedelic drug ibogaine, with potential for treating addiction, depression and other psychiatric disorders, has been developed by researchers.
source https://www.sciencedaily.com/releases/2020/12/201209115232.htm
Thursday, 10 December 2020
Related Posts
After California’s 3rd-largest wildfire, deer returned home while trees were ‘still smoldering’
Reducing vessel activity key to southern resident killer whale survival
Cleveland Clinic study links gut microbiome and aggressive prostate cancer
Stacking the deck: Layers of crystalline nanosheets enable tunable electronic properties
Best water treading technique to prevent drowning
New research casts doubt on claims that people have ‘rose-tinted glasses’
0 comments: